← Back to catalogue

IMMULITE® Systems TBG CONTROL

FDA UDI

Class II (US FDA UDI)

by Siemens Healthcare Diagnostics Products Ltd

Identity

Trade Name
IMMULITE® Systems TBG CONTROL FDA UDI
Generic Name
Thyroxine binding globulin (TBG) IVD, control FDA UDI
Device Name
TBG - IMMULITE - CTL - 2x2.0mL FDA UDI
Model / Reference
10385244 FDA UDI
Description
TBG - IMMULITE - CTL - 2x2.0mL FDA UDI

Identifiers

Catalog Number
LTBCM FDA UDI
Primary DI / UDI-DI
00630414953298 FDA UDI
510(k) Number
K950072 FDA UDI
FDA Product Code
CEE FDA UDI
GMDN Term
Thyroxine binding globulin (TBG) IVD, control FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
862.1685 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Thyroxine binding globulin (TBG) IVD, control

IMMULITE® Systems TBG CONTROL by Siemens Healthcare Diagnostics Products Ltd — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Thyroxine binding globulin (TBG) IVD, control.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 2f0191d2-9b71-4efd-a4cd-96efb2352c7d 37 fields · synced Jun 8, 2026